Congressional Research Service Reports - 200 Matching Results

Search Results

Medicare Prescription Drug Provisions of S.1, as Passed by the Senate, and H.R. 1, as Passed by the House
This report discusses differences in the specifics of the prescription drug provisions in S. 1 and H.R. 1 and provides a side-by-side comparison of the Title I provisions of both bills.
Products Liability: A Legal Overview
No Description Available.
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description Available.
Telemarketing: Dealing with Unwanted Telemarketing Calls
This report provides summaries of the federal laws and regulations particular to telemarketing, the establishment of a national do-not-call registry, and the options that are available to consumers to limit the calls that they receive from telemarketers and to report questionable telemarketing practices to local or federal authorities. The report also lists sources of additional information with addresses, phone numbers, and Internet sites (if available).
Slamming: The Unauthorized Change of a Consumer's Telephone Service Provider
No Description Available.
Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits
This report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plans.
Class Actions and Proposed Reform in the 108th Congress: Class Action Fairness Act of 2003
The report discusses the consumer class action bill of rights in each proposal contains safeguards which provide for judicial scrutiny of coupon and other non-cash settlements, protection against a proposed settlement that would result in a net loss to a class member, protection against discrimination based upon geographic location, and prohibition on a class representative receiving a greater share of the award.
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description Available.
Medicare Prescription Drug and Reform Legislation
This report describes the major features of S. 1, as ordered reported, and the measure to be considered by the House Ways and Means Committee, H.R. 2473, as ordered reported.
Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits
This report examines these proposals as well as the “Medicare Rx Drug Benefit and Discount Act of 2003,” which was introduced by Representative Charles Rangel, the ranking member of the House Ways and Means Committee. Specifically, this report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs.
Products Liability: A Legal Overview
No Description Available.
U.S. Tobacco Production, Consumption, and Export Trends
No Description Available.
U.S. Tobacco Production, Consumption, and Export Trends
No Description Available.
Slamming: The Unauthorized Change of a Consumer's Telephone Service Provider
No Description Available.
Consumer Bankruptcy and Household Debt
Financial distress is most common among lower-income families, but its incidence has grown in all income brackets. This trend suggests that explanations for the rise in consumer bankruptcy filings are more likely to be found in micro-analysis of individuals and groups of debtors than in macroeconomic indicators. This report presents statistics on bankruptcy filings, household debt, and households in financial distress.
Telemarketing: Dealing with Unwanted Telemarketing Calls
This report provides summaries of the federal laws and regulations particular to telemarketing, the establishment of a national do-not-call registry, and the options that are available to consumers to limit the calls that they receive from telemarketers and to report questionable telemarketing practices to local or federal authorities. The report also lists sources of additional information with addresses, phone numbers, and Internet sites (if available).
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Protection of Lawful Commerce in Arms Act, H.R. 1036, 108th Congress: Legal Analysis
No Description Available.
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description Available.
Identity Theft and the Fair Credit Reporting Act: An Analysis of
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Slamming: The Unauthorized Change of a Consumer's Telephone Service Provider
No Description Available.
Consumer Bankruptcy and Household Debt
Financial distress is most common among lower-income families, but its incidence has grown in all income brackets. This trend suggests that explanations for the rise in consumer bankruptcy filings are more likely to be found in micro-analysis of individuals and groups of debtors than in macroeconomic indicators. This report presents statistics on bankruptcy filings, household debt, and households in financial distress.
Identity Theft and the Fair Credit Reporting Act: An Analysis of
No Description Available.
President Bush's Proposed Medicare-Endorsed Drug Discount Card Initiative: Status and Issues
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Ecstasy: Legislative Proposals in the 107th Congress to Control MDMA
Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin.
Slamming: The Unauthorized Change of a Consumer's Telephone Service Provider
No Description Available.
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description Available.
Telemarketing: Dealing With Unwanted Telemarketing Calls
This report provides summaries of the federal laws and regulations particular to telemarketing, the establishment of a national do-not-call registry, and the options that are available to consumers to limit the calls that they receive from telemarketers and to report questionable telemarketing practices to local or federal authorities. The report also lists sources of additional information with addresses, phone numbers, and Internet sites (if available).
Products Liability: A Legal Overview
No Description Available.
Homeland Security Act of 2002: Tort Liability Provisions
No Description Available.
The Hatch-Waxman Act: Proposed Legislative Changes Affecting Pharmaceutical Patents
No Description Available.
Slamming: The Unauthorized Change of a Consumer's Telephone Service Provider
No Description Available.
Ecstasy: Actions of the 107th Congress to Control MDMA
Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin.
President Bush's Proposed Medicare-Endorsed Drug Discount Card Initiative: Status and Issues
No Description Available.
Telemarketing: Dealing With Unwanted Telemarketing Calls
This report provides summaries of the federal laws and regulations particular to telemarketing, the establishment of a national do-not-call registry, and the options that are available to consumers to limit the calls that they receive from telemarketers and to report questionable telemarketing practices to local or federal authorities. The report also lists sources of additional information with addresses, phone numbers, and Internet sites (if available).
Products Liability: A Legal Overview
No Description Available.
Two Key Provisions in the Bankruptcy Reform Act Conference Report: The Homestead Exemption and Dischargeability of Liability for Violations of Laws Relating to the Provision of "Lawful Goods and Services"
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Consumer Bankruptcy and Household Debt
Financial distress is most common among lower-income families, but its incidence has grown in all income brackets. This trend suggests that explanations for the rise in consumer bankruptcy filings are more likely to be found in micro-analysis of individuals and groups of debtors than in macroeconomic indicators. This report presents statistics on bankruptcy filings, household debt, and households in financial distress.
The Hatch-Waxman Act: Proposed Legislative Changes
No Description Available.
Importing Prescription Drugs
No Description Available.
Ecstasy: Actions of the 107th Congress to Control MDMA
Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin.
Medicare: Major Prescription Drug Provisions of Selected Bills
No Description Available.
Slamming: The Unauthorized Change of a Consumer's Telephone Service Provider
No Description Available.
Comparison of Two Key Provisions in the Bankruptcy Reform Act Conference Report: The Homestead Exemption and Dischargeability of Liability for Abortion Clinic Violence
This report examines two provisions in the Conference Report on the Bankruptcy Abuse Prevention and Consumer Protection Act of 2002, H.R. 107-617, 107th Cong., 2d Sess. (2002): the homestead exemption and dischargeability of liability for abortion clinic violence.